SCHEMBL1406872

SCHEMBL1406872

CCOC(=O)c1cnn(C2CCCC2)c1N

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.64
RAB9A P51151 4/20 0.53
NPC1 O15118 4/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 5/20 0.52
HPGD P15428 3/20 0.52
TSHR P16473 3/20 0.51
KMT2A Q03164 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MEN1 O00255 1/20 0.51
TP53 P04637 1/20 0.48
HTT P42858 2/20 0.47
CSNK1D P48730 1/20 0.46
MAPT P10636 2/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PDE4B Q07343 1/20 0.45
POLB P06746 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1407107 0.99 LMNA (0.66) LMNARAB9ANPC1KDM4EALDH1A1
SCHEMBL1407590 0.97 LMNA (0.60) LMNARAB9ANPC1KDM4EALDH1A1
SCHEMBL1407224 0.94 LMNA (0.60) LMNARAB9ANPC1KDM4EALDH1A1
SCHEMBL4722879 0.93 LMNA (0.57) LMNARAB9ANPC1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL4714551 0.92 LMNA (0.56) LMNARAB9ANPC1KDM4EALDH1A1
SCHEMBL1407077 0.90 LMNA (0.55) LMNARAB9ANPC1KDM4EALDH1A1
SCHEMBL1407071 0.90 LMNA (0.55) LMNARAB9ANPC1KDM4EALDH1A1
SCHEMBL1407074 0.90 LMNA (0.55) LMNARAB9ANPC1KDM4EALDH1A1
SCHEMBL1406723 0.88 LMNA (0.54) LMNARAB9ANPC1KDM4EALDH1A1
SCHEMBL4346096 0.88 LMNA (0.54) LMNARAB9ANPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999114-B1 PYRAZOLES AS 11-BETA-HSD-1 HOFFMANN LA ROCHE (CH) 2015-07-22 EP disclosed
EP-2295411-A1 Pyrazoles as 11-beta-hsd-1 F. Hoffmann-La Roche AG (CH) 2011-03-16 EP disclosed
US-7728029-B2 Adamantyl-pyrazole carboxamides as inhibitors of 11β-hdroxysteroid dehydrogenase HOFFMANN-LA ROCHE INC. (US) 2010-06-01 US disclosed
EP-1999114-A2 PYRAZOLES AS 11-BETA-HSD-1 F. Hoffmann-la Roche AG (CH) 2008-12-10 EP disclosed
WO-2007107470-A2 PYRAZOLES AS 11-BETA-HSD-1 F. HOFFMANN-LA ROCHE AG (CH) 2007-09-27 WO disclosed
US-20070225280-A1 Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase ANDERSON KEVIN WILLIAM 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225280-A1 Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase HSD3B2, HSD3B1, HSD17B2 LMNA 2991/4885RAB9A 1814/4885NPC1 856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.